References
1a
Larsen RD.
Corley EG.
King AO.
Carrol JD.
Davis P.
Verhoeven TR.
Reider PJ.
Labelle M.
Gauthier JY.
Xiang YB.
Zamboni RJ.
J. Org. Chem.
1996,
61:
3398
1b
Chen YL.
Fang KC.
Sheu J.-Y.
Hsu SL.
Tzeng CC.
J. Med. Chem.
2001,
44:
2374
1c
Roma G.
Braccio MD.
Grossi G.
Mattioli F.
Ghia M.
Eur. J. Med. Chem.
2000,
35:
1021
2a
Kalluraya B.
Sreenivasa S.
Farmaco
1998,
53:
399
2b
Doube D.
Blouin M.
Brideau C.
Chan C.
Desmarais S.
Eithier D.
Falgueyret JP.
Friesen RW.
Girard M.
Girard Y.
Guay J.
Tagari P.
Young RN.
Bioorg. Med. Chem. Lett.
1998,
8:
1255
3
Maguire MP.
Sheets KR.
McVety K.
Spada AP.
Zilberstein A.
J. Med. Chem.
1994,
37:
2129
4a
Agarwal AK.
Jenekhe SA.
Macromolecules
1991,
24:
6806
4b
Zhang X.
Shetty AS.
Jenekhe SA.
Macromolecules
1999,
32:
7422
4c
Zhang X.
Shetty AS.
Jenekhe SA.
Macromolecules
2000,
33:
2069
4d
Jenekhe SA.
Lu L.
Alam MM.
Macromolecules
2001,
34:
7315
5a
Jones G.
In Comprehensive Heterocyclic Chemistry II
Vol. 5:
Katritzky AR.
Rees CW.
Pergamon Press;
New York:
1996.
p.167
5b
Cho CS.
Oh BH.
Kim TJ.
Shim SC.
Chem. Commun.
2000,
1885 ; and references therein
5c
Jiang B.
Si Y.-C.
J. Org. Chem.
2002,
67:
9449
6a
Skraup H.
Chem. Ber.
1880,
13:
2086
6b
Friedländer P.
Ber.
1882,
15:
2572
6c
Mansake RHF.
Kulka M.
Org. React.
1953,
7:
59
6d
Linderman RJ.
Kirollos SK.
Tetrahedron Lett.
1990,
31:
2689
6e
Theoclitou M.-E.
Robinson LA.
Tetrahedron Lett.
2002,
43:
3907
7a
Cheng C.-C.
Yan S.-J.
Org. React.
1982,
28:
37
7b
Thummel RP.
Synlett
1992,
1
7c
Eckert H.
Angew. Chem., Int. Ed. Engl.
1981,
20:
208
7d
Gladiali S.
Chelucci G.
Mudadu MS.
Gastaut MA.
Thummel RP.
J. Org. Chem.
2001,
66:
400
8
Fehnel EA.
J. Heterocycl. Chem.
1966,
31:
2899
9a
Strekowski L.
Czamy A.
J. Fluor. Chem.
2000,
104:
281
9b
Hu Y.-Z.
Zang G.
Thummel RP.
Org. Lett.
2003,
5:
2251
10a
Kwon TW.
Song SJ.
Cho SJ.
Tetrahedron Lett.
2003,
44:
255
10b
Yadav JS.
Reddy BVS.
Rao RS.
Kumar VN.
Nagaiah K.
Synthesis
2003,
1610
10c
Cho SC.
Oh BO.
Shin SC.
Tetrahedron Lett.
1999,
40:
1499
11a
Arcadi A.
Chiarini M.
Di Giuseppe S.
Marinelli F.
Synlett
2003,
203
11b
McNaughton BR.
Miller BL.
Org. Lett.
2003,
5:
4257
11c
Walser A.
Flyll T.
Fryer RI.
J. Heterocycl. Chem.
1975,
12:
737
12
Repichet S.
Zwick A.
Vendier L.
Le Roux C.
Dubac J.
Tetrahedron Lett.
2002,
43:
993
13
Leonard MN.
Wieland LC.
Mohan RS.
Tetrahedron
2002,
58:
8373
14
General Procedure: A mixture of the 2-aminoaryl ketone (1.0 mmol), α-methylene ketone (1.2 mmol) and Bi(OTf)3 or Sc(OTf)3 (5 mol%) in EtOH (10 mL) was stirred at r.t. for the specified time (see Table
[1]
). After completion of the reaction as indicated by TLC, the reaction mixture was quenched with water (15 mL) and extracted with EtOAc (2 × 10 mL). Evaporation of the solvent followed by purification on silica gel (Merck, 100-200 mesh, EtOAc-hexane, 0.5:9.5) afforded pure quinoline. Spectral data for selected products: 3a: 3-Acetyl-2-methyl-4-phenyl-quinoline: Solid; mp 115 °C. IR (KBr): 3027, 2960, 1705, 1610, 1569, 1485, 705 cm-1. 1H NMR (200 MHz, CDCl3): δ = 1.95 (s, 3 H), 2.60 (s, 3 H), 7.25-7.30 (m, 2 H), 7.35 (t, J = 8.0 Hz, 1 H), 7.40-7.50 (m, 3 H), 7.55 (d, J = 8.2 Hz, 1 H), 7.65 (t, J = 8.0 Hz, 1 H), 8.0 (d, J = 8.2 Hz, 1 H). EIMS: m/z (%) = 261 (75) [M+], 246 (100), 218 (80), 176 (50), 150 (20), 43 (30). 3b: Ethyl 2-methyl-4-phenyl-quinoline-3-carboxylate : Solid; mp 98 °C. IR (KBr): 3030, 2960, 1700, 1605, 1568, 1482, 905 cm-1. 1H NMR (200 MHz, CDCl3): δ = 0.95 (t, J = 7.0 Hz, 3 H), 2.80 (s, 3 H), 4.05 (q, J = 7.0 Hz, 2 H), 7.35-7.50 (m, 6 H), 7.55 (d, J = 8.1 Hz, 1 H), 7.70 (t, J = 7.9 Hz, 1 H), 8.05 (d, J = 8.1 Hz, 1 H). EIMS: m/z (%) = 291 (85) [M+], 263 (10), 246 (100), 218 (60), 176 (40), 150 (20). 3f: 9-Phenyl-1,2,3,4-tetrahydroacridine: Solid; mp 137 °C. IR (KBr): 3057, 2945, 1609, 1575, 1480, 1210, 708 cm-1. 1H NMR (200 MHz, CDCl3): δ = 1.75-1.85 (m, 2 H), 1.95-2.05 (m, 2 H), 2.60 (t, J = 6.7 Hz, 2 H), 3.20 (t, J = 6.9 Hz, 2 H), 7.20-7.32 (m, 3 H), 7.40-7.60 (m, 5 H), 8.0 (d, J = 8.2 Hz, 1 H). EIMS: m/z (%) = 259 (100) [M+], 230 (30), 182 (10), 176 (12), 57 (25). 3h: 3,3-Dimethyl-9-phenyl-1,2,3,4-tetrahydro-1-acridinone: Solid; mp 197 °C. IR (KBr): 3060, 2958, 1710, 1601, 1575, 1208, 735 cm-1. 1H NMR (200 MHz, CDCl3): δ = 1.20 (s, 6 H), 2.55 (s, 2 H), 3.30 (s, 2 H), 7.10-7.20 (m, 2 H), 7.35-7.50 (m, 5 H), 7.75 (t, J = 7.9 Hz, 1 H), 8.05 (d, J = 8.1 Hz,1 H). EIMS: m/z (%) = 301 (100) [M+], 272 (70), 246 (60), 218 (45), 190 (10). 3k: 6-Chloro-3-acetyl-2-methyl-4-phenyl-quinoline: Solid; mp 150 °C. IR (KBr): 3028, 2960, 1703, 1609, 1570, 1485, 901 cm-1. 1H NMR (200 MHz, CDCl3): δ = 2.0 (s, 3 H), 2.60 (s, 3 H), 7.35-7.40 (m, 2 H), 7.60-7.70 (m, 3 H), 8.20 (d, J = 8.0 Hz, 1 H), 8.45-8.55 (m, 2 H). EIMS: m/z (%) = 295 (65) [M+], 280 (100), 252 (30), 217 (40), 189 (20), 176 (50), 109 (10). 3n: Ethyl 6-chloro-4-(2-fluorophenyl)-2-methyl-3-quinolinecarboxylate: Solid; mp 114 °C. IR (KBr): 3029, 2960, 1702, 1601, 1570, 1483, 900 cm-1. 1H NMR (200 MHz, CDCl3): δ = 0.98 (t, J = 7.0 Hz, 3 H), 2.80 (s, 3 H), 4.06 (q, J = 7.0 Hz, 2 H), 7.20-7.30 (m, 3 H), 7.38-7.70 (m, 3 H), 8.05 (d, J = 8.2 Hz, 1 H). EIMS: m/z (%) = 342 (100) [M+], 298 (90), 270 (45), 236 (40), 194 (40), 177 (10), 71 (10), 57 (38).